Level Chart

Level Chart

Basic Info

Boston Scientific Corp (BSX) - MedSurg Revenue is at a current level of 1.701B, down from 1.809B last quarter and up from 1.577B one year ago. This is a change of -5.97% from last quarter and 7.86% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.701B
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Average Growth Rate 13.43%
Value from Last Quarter 1.809B
Change from Last Quarter -5.97%
Value from 1 Year Ago 1.577B
Change from 1 Year Ago 7.86%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 1.701B
December 31, 2025 1.809B
September 30, 2025 1.722B
June 30, 2025 1.716B
March 31, 2025 1.577B
December 31, 2024 1.619B
September 30, 2024 1.479B
June 30, 2024 1.483B
March 31, 2024 1.412B
December 31, 2023 1.441B
September 30, 2023 1.341B
June 30, 2023 1.36B
March 31, 2023 1.28B
Date Value
December 31, 2022 1.297B
September 30, 2022 1.213B
June 30, 2022 1.248B
March 31, 2022 1.153B
December 31, 2021 1.243B
September 30, 2021 1.138B
June 30, 2021 1.195B
March 31, 2021 1.058B
December 31, 2020 892.00M
September 30, 2020 825.00M
June 30, 2020 576.00M
March 31, 2020 774.00M
December 31, 2019 878.00M

Basic Info

Boston Scientific Corp (BSX) - MedSurg Revenue is at a current level of 1.701B, down from 1.809B last quarter and up from 1.577B one year ago. This is a change of -5.97% from last quarter and 7.86% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 1.701B
Latest Period Mar 2026
Last Updated Jul 29 2026, 08:30 EDT
Next Release Oct 21 2026, 08:30 EDT (E)
Average Growth Rate 13.43%
Value from Last Quarter 1.809B
Change from Last Quarter -5.97%
Value from 1 Year Ago 1.577B
Change from 1 Year Ago 7.86%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. -2.94%